Twinlab launches liver detox formulated for athletes
GRAND RAPIDS, Mich. Twinlab on Friday announced the launch of Liver D-Tox Fuel, a daily liver detoxifying formula that combines L-glutathione and alpha lipoic acid along with an exclusive Purification Matrix formula.
Designed with athletes in mind, Liver D-Tox is made with natural ingredients and contains no harsh chemicals that interfere with the natural detoxification process.
“Most people would benefit from a detoxifying product, but athletes have additional needs,” stated Thane Slagowski, Twinlab director of research and development. “Not only do they introduce more free radicals into their system through intense exercise, but the additional stresses they put on their body also increase the toxins in their system, making their liver work even harder.”
L-Glutathione and alpha lipoic acid are antioxidants that help to dissolve toxic substances and maintain healthy enzyme levels, the company stated. The Purification Matrix formula contains: kudzu (root) powder and extract, milk thistle (seed) extract (standardized to 80 percent silymarin), artichoke (aerial part) and sarsaparilla (root).
Amerifit launches trio of brand Web sites
CROMWELL, Conn. Amerifit Brands on Monday announced the Web site launches of three of its top consumer health brands: Estroven.com, Culturelle.com and AzoProducts.com.
“We have made significant improvements to the websites of three Amerifit Brands companies with new features and capabilities that we believe will serve as valuable resources to consumers looking to maintain and improve their health,” stated Cyrill Siewert, chief executive officer of Amerifit Brands.
Estroven.com offers perimenopausal and menopausal women (ages 40–60) an updated platform where they can find women’s health and menopause-related information. Women are encouraged to visit the website’s unique Lifestyle Lounge, where they can read and share stories and jokes about menopause.
FDA seizes over $300,000 of product from General Theraputics
ROCKVILLE, Md. The Food and Drug Administration on Wednesday directed the seizure of more than $300,000 worth of product, including NC Solution, an antifungal product, and other drugs for human or animal use, dietary supplements and the ingredients to make those products because some lacked FDA approval and all were maintained under what the FDA defined as “grossly unsanitary conditions” by General Therapeutics of St. Louis, Mo.
“The action taken Wednesday is the culmination of the concerted efforts by the FDA to get the firm to follow the law when it comes to manufacturing safe products for consumers,” stated Margaret Glavin, FDA associate commissioner for regulatory affairs.
The FDA considers NC Solution to be a drug because it is intended for the use in the diagnosis, cure, or treatment of disease in people or animals. NC Solution is also a new drug because it is not generally recognized as safe and effective for its intended uses.
In August and September, FDA inspectors found that the company was still manufacturing drugs and dietary supplements under unsanitary conditions, including insects and rodent filth on and around manufacturing equipment, despite a warning by FDA of serious violations in 1999. Following the 1999 inspection, a company official told the FDA in January, 2000, it would stop manufacturing drugs.
The FDA recommends that consumers who have any products manufactured by General Therapeutics, including NC Solution, consult their health care providers about discontinuing use and if they have experienced any adverse events that they suspect are related to the product’s use.
Catherine Hanaway, U.S. attorney for the Eastern District of Missouri, filed the complaint requesting the seizure, and her office will continue to coordinate with the FDA to ensure proper disposal of the seized items.